TrialEuropean journal of cancer (Oxford, England : 1990)2014

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib.

Atul B Shinagare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.